Tankyrase-1 assembly to large protein complexes blocks its telomeric function

FEBS Letters

Volumn 584, Issue 18, 2010, Pages 3885-3890

  Hatsugai, Kaori ^a,b   Ohishi, Tomokazu ^a   Sugimoto, Yoshikazu ^a,b   Seimiya, Hiroyuki ^a  

^a CANCER CHEMOTHERAPY CENTER   (Japan)

^b KEIO UNIVERSITY   (Japan)

Author keywords

Poly(ADP ribose) polymerase; Tankyrase 1; Telomere; TRF1

Indexed keywords

TANKYRASE; TANKYRASE 1 PROTEIN; TELOMERIC REPEAT BINDING FACTOR 1; UNCLASSIFIED DRUG; HISTONE DEACETYLASE INHIBITOR; MULTIENZYME COMPLEX; TNKS PROTEIN, HUMAN;

ARTICLE; CELL NUCLEUS; CONTROLLED STUDY; HUMAN; HUMAN CELL; PRIORITY JOURNAL; PROTEIN ASSEMBLY; PROTEIN EXPRESSION; PROTEIN FUNCTION; PROTEIN MULTIMERIZATION; PROTEIN PROTEIN INTERACTION; PROTEIN SECRETION; TELOMERE; ANTAGONISTS AND INHIBITORS; DRUG EFFECTS; ENZYMOLOGY; GENE EXPRESSION; GENETICS; HELA CELL LINE; IMMUNOPRECIPITATION; METABOLISM; PHYSIOLOGY; PROMOTER REGION; PROTEIN TERTIARY STRUCTURE;

GENE EXPRESSION; HELA CELLS; HISTONE DEACETYLASE INHIBITORS; HUMANS; IMMUNOPRECIPITATION; MULTIENZYME COMPLEXES; PROMOTER REGIONS, GENETIC; PROTEIN STRUCTURE, TERTIARY; TANKYRASES; TELOMERE;

EID: 77956905098     PISSN: 00145793     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.febslet.2010.07.062     Document Type: Article

References (19)

1. Smith S., Giriat I., Schmitt A., de Lange T. Tankyrase, a poly(ADP-ribose) polymerase at human telomeres. Science 1998, 282:1484-1487.
2. Smith S., de Lange T. Tankyrase promotes telomere elongation in human cells. Curr. Biol. 2000, 10:1299-1302.
3. Seimiya H., Muramatsu Y., Ohishi T., Tsuruo T. Tankyrase 1 as a target for telomere-directed molecular cancer therapeutics. Cancer Cell 2005, 7:25-37.
4. Seimiya H. The telomeric PARP, tankyrases, as targets for cancer therapy. Br. J. Cancer 2006, 94:341-345.
5. Seimiya H., Smith S. The telomeric poly(ADP-ribose) polymerase, tankyrase 1, contains multiple binding sites for telomeric repeat binding factor 1 (TRF1) and a novel acceptor, 182-kDa tankyrase-binding protein (TAB182). J. Biol. Chem. 2002, 277:14116-14126.
6. Seimiya H., Muramatsu Y., Smith S., Tsuruo T. Functional subdomain in the ankyrin domain of tankyrase 1 required for poly(ADP-ribosyl)ation of TRF1 and telomere elongation. Mol. Cell Biol. 2004, 24:1944-1955.
7. Sbodio J.I., Lodish H.F., Chi N.W. Tankyrase-2 oligomerizes with tankyrase-1 and binds to both TRF1 (telomere-repeat-binding factor 1) and IRAP (insulin-responsive aminopeptidase). Biochem. J. 2002, 361:451-459.
8. De Rycker M., Price C.M. Tankyrase polymerization is controlled by its sterile alpha motif and poly(ADP-ribose) polymerase domains. Mol. Cell Biol. 2004, 24:9802-9812.
9. Ohishi T., Hirota T., Tsuruo T., Seimiya H. TRF1 mediates mitotic abnormalities induced by Aurora-A overexpression. Cancer Res. 2010, 70:2041-2052.
10. Ohishi T., Tsuruo T., Seimiya H. Evaluation of tankyrase inhibition in whole cells. Methods Mol. Biol. 2007, 405:133-146.
11. Chang W., Dynek J.N., Smith S. TRF1 is degraded by ubiquitin-mediated proteolysis after release from telomeres. Genes Dev. 2003, 17:1328-1333.
12. Kawada M., Inoue H., Masuda T., Ikeda D. Insulin-like growth factor I secreted from prostate stromal cells mediates tumor-stromal cell interactions of prostate cancer. Cancer Res. 2006, 66:4419-4425.
13. Tanaka J., Sadanari H., Sato H., Fukuda S. Sodium butyrate-inducible replication of human cytomegalovirus in a human epithelial cell line. Virology 1991, 185:271-280.
14. Gelmini S., Poggesi M., Distante V., Bianchi S., Simi L., Luconi M., et al. Tankyrase, a positive regulator of telomere elongation, is over expressed in human breast cancer. Cancer Lett. 2004, 216:81-87.
15. Xu D., Zheng C., Bergenbrant S., Holm G., Bjorkholm M., Yi Q., et al. Telomerase activity in plasma cell dyscrasias. Br. J. Cancer 2001, 84:621-625.
16. McCabe N., Cerone M.A., Ohishi T., Seimiya H., Lord C.J., Ashworth A. Targeting Tankyrase 1 as a therapeutic strategy for BRCA-associated cancer. Oncogene 2009, 28:1465-1470.
17. Huang S.M., Mishina Y.M., Liu S., Cheung A., Stegmeier F., Michaud G.A., et al. Tankyrase inhibition stabilizes axin and antagonizes Wnt signalling. Nature 2009, 461:614-620.
18. Zhou H., Kuang J., Zhong L., Kuo W.L., Gray J.W., Sahin A., et al. Tumour amplified kinase STK15/BTAK induces centrosome amplification, aneuploidy and transformation. Nat. Genet. 1998, 20:189-193.
19. Yashiroda Y., Okamoto R., Hatsugai K., Takemoto Y., Goshima N., Saito T., et al. A novel yeast cell-based screen identifies flavone as a tankyrase inhibitor. Biochem. Biophys. Res. Commun. 2010, 394:569-573.